Literature DB >> 3151164

Reciprocal renal effects of dopamine and 5-hydroxytryptamine formed within the rat kidney.

H D Itskovitz1, Y H Chen, C T Stier.   

Abstract

1. Clearance of inulin and p-aminohippurate and excretion of water and sodium were measured for eight to 11 clearance periods of 20 min duration in anaesthetized, 3% volume-expanded rats, before and after intravenous infusions of the amino acids L-dopa (L-3,4-dihydroxyphenylalanine) and 5-hydroxytryptophan. During the final two clearance periods, the peripheral decarboxylase inhibitor, carbidopa (S-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate), was infused additionally. 2. Renal formation of dopamine (3,4-dihydroxyphenethylamine) and 5-hydroxytryptamine was demonstrated during infusions of L-dopa and 5-hydroxytryptophan, respectively; carbidopa blocked the renal formation of these biogenic amines. 3. During infusion of dopa, a diuresis and a natriuresis were observed; during the infusion of 5-hydroxytryptophan, slight reductions in clearances of inulin and p-aminohippurate, but significant reductions in sodium and water excretion, were measured. 4. The addition of carbidopa diminished diuretic and natriuretic responses to dopa as renal dopamine excretion decreased; the infusion of carbidopa also ameliorated the antinatriuretic and antidiuretic effects of 5-hydroxytryptophan, as 5-hydroxytryptamine excretion decreased. 5. Although dopa and 5-hydroxytryptophan are substrates for the same enzyme, aromatic L-amino-acid decarboxylase, simultaneous infusions of both amino acids at comparable rates gave no evidence of competitive inhibition of amine synthesis. However, the infusion of dopa, after 5-hydroxytryptophan, decreased its antinatriuretic and antidiuretic effects. 6. These data raise the possibility that dopamine and 5-hydroxytryptamine are formed as reciprocal intrarenal hormones by the identical enzyme, aromatic L-amino-acid decarboxylase, which is located within cells of the renal tubule.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3151164     DOI: 10.1042/cs0750503

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

1.  Hormonal-dependent recruitment of Na+,K+-ATPase to the plasmalemma is mediated by PKC beta and modulated by [Na+]i.

Authors:  Claudia E Budu; Riad Efendiev; Angel M Cinelli; Alejandro M Bertorello; Carlos H Pedemonte
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Antagonistic actions of renal dopamine and 5-hydroxytryptamine: endogenous 5-hydroxytryptamine, 5-HT1A receptors and antinatriuresis during high sodium intake.

Authors:  P Soares-da-Silva; M A Vieira-Coelho; M Pestana
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Antagonistic actions of renal dopamine and 5-hydroxytryptamine: increase in Na+, K(+)-ATPase activity in renal proximal tubules via activation of 5-HT1A receptors.

Authors:  P Soares-da-Silva; P C Pinto-do-O; A M Bertorello
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Antagonistic actions of renal dopamine and 5-hydroxytryptamine: effects of amine precursors on the cell inward transfer and decarboxylation.

Authors:  P Soares-da-Silva; P C Pinto-do-O
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

5.  Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.

Authors:  P Soares-da-Silva; M Pestana; M A Vieira-Coelho; M H Fernandes; A Albino-Teixeira
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

6.  Blood and urine 5-hydroxytryptophan and 5-hydroxytryptamine levels after administration of two 5-hydroxytryptamine precursors in normal man.

Authors:  T C Wa; N J Burns; B C Williams; S Freestone; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

7.  A comparison of the effects of two putative 5-hydroxytryptamine renal prodrugs in normal man.

Authors:  T C Li Kam Wa; S Freestone; R R Samson; N R Johnston; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

8.  Dissociation of the antimicrobial activity of bacitracin USP from its renovascular effects.

Authors:  G Drapeau; E Petitclerc; A Toulouse; F Marceau
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

9.  Detection of six novel de novo mutations in individuals with low resilience to psychological stress.

Authors:  Esfandiar Azadmarzabadi; Arvin Haghighatfard
Journal:  PLoS One       Date:  2021-09-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.